Pulmonary Arterial Hypertension (PAH) Market Competition by Manufacturers, Share, Size and Development Trends 2025
20 February 2020 - The global Pulmonary Arterial Hypertension (PAH) Market size was valued at USD 5.0 billion in 2015 and is anticipated to reach USD 8.7 billion by 2025. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. These arteries are called pulmonary arteries. PAH occurs when the pulmonary arteries thicken or grow rigid. PAH is one of the five groups of pulmonary hypertension, classified by the World Health Organization (WHO). The market for PAH is growing moderately due to newer launches of pipeline drugs that target different pathways to suppress the symptoms of the disease. Early diagnosis of the disease has played a pivotal role in number of patients undergoing treatment. View Full Report with TOC @ https://www.millioninsights.com/industry-reports/pulmonary-arterial-hypertension-pah-market Globally the PAH market is seg...